CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

GSK shares kept at neutral by Citi as unproven phase III pipeline curbs long-term growth

Neutral
AI Analysis

Summary

Citi maintained a neutral rating on GSK, citing concerns that an unproven Phase III pipeline may limit long-term growth prospects for the pharmaceutical company.

Importance:3/10
Sentiment:
-0.20
analyst_ratingpipelinephase_3growth_concerns
Related Companies

Read the original article

Published by yahoo_finance on August 20, 2026 1:00 PM

Read Original